Oestrogen receptor beta: what it means for patients with breast cancer
- PMID: 15003201
- DOI: 10.1016/S1470-2045(04)01413-5
Oestrogen receptor beta: what it means for patients with breast cancer
Erratum in
- Lancet Oncol. 2004 Apr;5(4):208
Abstract
Oestrogen receptor (ER) alpha is a well established prognostic marker in breast cancer, and all patients who are ER alpha positive receive tamoxifen as adjuvant endocrine therapy. Although ER alpha predicts a favourable disease outcome, the usefulness of ER beta as a clinical prognostic marker remains to be defined. Here, we outline the history of both ERs and discuss the implications ER beta has to patients with breast cancer.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
